[go: up one dir, main page]

WO1997005251A3 - Feline stem cell factor - Google Patents

Feline stem cell factor Download PDF

Info

Publication number
WO1997005251A3
WO1997005251A3 PCT/GB1996/001904 GB9601904W WO9705251A3 WO 1997005251 A3 WO1997005251 A3 WO 1997005251A3 GB 9601904 W GB9601904 W GB 9601904W WO 9705251 A3 WO9705251 A3 WO 9705251A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cell
cell factor
feline stem
feline
polynucleotide fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1996/001904
Other languages
French (fr)
Other versions
WO1997005251A2 (en
Inventor
Stephen Peter Dunham
David Edward Onions
Gillian Margaret Lees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Q-one Biotech Ltd
Original Assignee
Q-one Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Q-one Biotech Ltd filed Critical Q-one Biotech Ltd
Priority to AU67457/96A priority Critical patent/AU6745796A/en
Publication of WO1997005251A2 publication Critical patent/WO1997005251A2/en
Publication of WO1997005251A3 publication Critical patent/WO1997005251A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides a polynucleotide fragment encoding feline stem cell factor, a recombinant vector comprising such a polynucleotide fragment, a host cell containing said polynucleotide fragment, a recombimant vector, a recombinant feline stem cell factor polypeptide, and pharmaceutical compositions comprising recombinant feline stem cell factor for use as a prophylactic and/or therapeutic agent.
PCT/GB1996/001904 1995-08-02 1996-08-02 Feline stem cell factor Ceased WO1997005251A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU67457/96A AU6745796A (en) 1995-08-02 1996-08-02 Feline stem cell factor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515839.0A GB9515839D0 (en) 1995-08-02 1995-08-02 Feline stem cell factor
GB9515839.0 1995-08-02

Publications (2)

Publication Number Publication Date
WO1997005251A2 WO1997005251A2 (en) 1997-02-13
WO1997005251A3 true WO1997005251A3 (en) 1997-04-17

Family

ID=10778647

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/001904 Ceased WO1997005251A2 (en) 1995-08-02 1996-08-02 Feline stem cell factor

Country Status (3)

Country Link
AU (1) AU6745796A (en)
GB (1) GB9515839D0 (en)
WO (1) WO1997005251A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005795A1 (en) * 1989-10-16 1991-05-02 Amgen Inc. Stem cell factor
WO1992000376A1 (en) * 1990-06-25 1992-01-09 Immunex Corporation Mast cell growth factor
WO1992003459A1 (en) * 1990-08-27 1992-03-05 Sloan-Kettering Institute For Cancer Research LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
WO1994009803A1 (en) * 1992-10-27 1994-05-11 Biotransplant, Inc. Enhancement of xenograft tolerance and porcine cytokines therefor
WO1995017206A1 (en) * 1993-12-22 1995-06-29 Amgen Inc. Lyophilized stem cell factor formulations

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005795A1 (en) * 1989-10-16 1991-05-02 Amgen Inc. Stem cell factor
WO1992000376A1 (en) * 1990-06-25 1992-01-09 Immunex Corporation Mast cell growth factor
WO1992003459A1 (en) * 1990-08-27 1992-03-05 Sloan-Kettering Institute For Cancer Research LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
WO1994009803A1 (en) * 1992-10-27 1994-05-11 Biotransplant, Inc. Enhancement of xenograft tolerance and porcine cytokines therefor
WO1995017206A1 (en) * 1993-12-22 1995-06-29 Amgen Inc. Lyophilized stem cell factor formulations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DUNHAM, S.P., ET AL .: "THE CLONING AND SEQUENCING OF cDNAs ENCODING TWO ISOFORMS OF FELINE STEM CELL FACTOR", DNA SEQUENCE, vol. 6, no. 4, 1996, pages 233 - 237, XP000647329 *

Also Published As

Publication number Publication date
GB9515839D0 (en) 1995-10-04
AU6745796A (en) 1997-02-26
WO1997005251A2 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
EP0962467A4 (en) Antibody against human parathormone related peptides
WO1995007994A3 (en) Recombinant alphavirus vectors
WO1996017072A3 (en) Recombinant alphavirus vectors
AUPP051497A0 (en) Antimicrobial peptides
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
AU7406694A (en) Novel b. burgdorferi polypeptides
AU2764997A (en) Udp-(n)-acetyl-alpha-d-galactosamine:polypeptide (n)-acetylgalactosaminyltransferase, galnac-t3
CA2204151A1 (en) Cdna encoding a bmp type ii receptor
EP0669396A4 (en) Novel polypeptide and dna coding for the same.
AU739516C (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
WO1996003435A3 (en) FELINE η-INTERFERON
AU6063900A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
WO2000058465A3 (en) Flint polypeptide analogs
WO1997005251A3 (en) Feline stem cell factor
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
ZA9710254B (en) LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
WO1996003436A3 (en) EQUINE η-INTERFERON
WO2000070036A3 (en) Genes expressed in hippocampus
AU1508601A (en) A novel polypeptide, a human histone h2a.21 and the polynucleotide encoding the polypeptide
AU9362801A (en) A novel polypeptide, a human protein 10 containing a group and the polynucleotide encoding the polypeptide
WO1990003394A3 (en) New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines
AU6015696A (en) Modified polypeptide, dna encoding the same, transformant, and medicinal composition containing the polypeptide
AU2769101A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
AU5887700A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA